Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Paris Sciences Lettres Quartier Latin — Human Necessities
Paris Sciences Lettres Quartier Latin holds 12 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Paris Sciences Lettres Quartier Latin |
| Technology | Human Necessities |
| Patents in slice | 12 |
| Recent patents in slice | 2 |
| First year | 2018 |
| Last year | 2025 |
Representative patents
Notable publications linking Paris Sciences Lettres Quartier Latin to Human Necessities.
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Methods and systems for in vivo full-field interference microscopy imaging
US-12076086-B2 · Sep 3, 2024 · US
Recent filings
Latest patents from Paris Sciences Lettres Quartier Latin in Human Necessities.
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-2025288544-A1 · Sep 18, 2025 · US
Methods and systems for in vivo full-field interference microscopy imaging
US-12076086-B2 · Sep 3, 2024 · US
Related pages
Navigate to parent entity pages.